Harrow, Inc.
HROW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001360214
In the last 90 days, Harrow, Inc. insiders filed 0 open-market purchases and 1 sale; 223 institutions reported holding it in 13F filings for Q2 2026, worth $912.6M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Harrow, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 112 | 129 | +17 |
| Shares | 23.0M | 24.9M | +1.91M (+8.3%) |
| Value | $437.6M | $358.7M | −$78.9M (−18.0%) |
New holders (25)
Institutions that held Harrow, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
Sold out (8)
Institutions that held Harrow, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Assenagon Asset Management S.A. | 884,208 | $16.8M |
| Jane Street Group, LLC | 126,055 | $2.40M |
| Walleye Capital LLC | 75,382 | $1.44M |
| EAM Investors, LLC | 56,806 | $1.08M |
| Calamos Advisors LLC | 49,608 | $944.5K |
| Optimum Investment Advisors | 1,200 | $22.8K |
| Aquatic Capital Management LLC | 300 | $6.00K |
| GWM Advisors LLC | 153 | $2.91K |